PHARMA-BIO SERV, INC. (PBSV) Net margin 2017–2025
PHARMA-BIO SERV, INC. (PBSV) net profit margin by fiscal year — reported net income divided by reported revenue.
-1.1%FY2025 · since FY2017: -10.6% → -1.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -1.1% | +7.1 pp |
| FY2024 | -8.2% | -15.9 pp |
| FY2023 | 7.7% | +2.5 pp |
| FY2022 | 5.2% | +15.6 pp |
| FY2021 | -10.4% | -19.9 pp |
| FY2020 | 9.5% | -1.2 pp |
| FY2019 | 10.7% | +3.5 pp |
| FY2018 | 7.2% | +17.8 pp |
| FY2017 | -10.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice